Baxter International Inc (BAX)
33.96
-0.23
(-0.67%)
USD |
NYSE |
Jun 25, 16:00
33.64
-0.32
(-0.94%)
Pre-Market: 07:50
Baxter International Research and Development Expense (TTM): 679.00M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 679.00M |
| December 31, 2023 | 667.00M |
| September 30, 2023 | 649.00M |
| June 30, 2023 | 634.00M |
| March 31, 2023 | 617.00M |
| December 31, 2022 | 603.00M |
| September 30, 2022 | 584.00M |
| June 30, 2022 | 562.00M |
| March 31, 2022 | 553.00M |
| December 31, 2021 | 531.00M |
| September 30, 2021 | 531.00M |
| June 30, 2021 | 525.00M |
| March 31, 2021 | 503.00M |
| December 31, 2020 | 521.00M |
| September 30, 2020 | 542.00M |
| June 30, 2020 | 563.00M |
| March 31, 2020 | 612.00M |
| December 31, 2019 | 595.00M |
| September 30, 2019 | 614.00M |
| June 30, 2019 | 636.00M |
| March 31, 2019 | 644.00M |
| December 31, 2018 | 655.00M |
| September 30, 2018 | 663.00M |
| June 30, 2018 | 647.00M |
| March 31, 2018 | 628.00M |
| Date | Value |
|---|---|
| December 31, 2017 | 615.00M |
| September 30, 2017 | 588.00M |
| June 30, 2017 | 597.00M |
| March 31, 2017 | 637.00M |
| December 31, 2016 | 646.00M |
| September 30, 2016 | 651.00M |
| June 30, 2016 | 640.00M |
| March 31, 2016 | 596.00M |
| December 31, 2015 | 603.00M |
| September 30, 2015 | 598.00M |
| June 30, 2015 | 599.00M |
| March 31, 2015 | 770.00M |
| December 31, 2014 | 936.00M |
| September 30, 2014 | 593.00M |
| June 30, 2014 | 721.00M |
| March 31, 2014 | 672.00M |
| December 31, 2013 | 609.00M |
| September 30, 2013 | 1.012B |
| June 30, 2013 | 1.025B |
| March 31, 2013 | 1.058B |
| December 31, 2012 | 1.081B |
| September 30, 2012 | 1.119B |
| June 30, 2012 | 1.068B |
| March 31, 2012 | 1.001B |
| December 31, 2011 | 946.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
503.00M
Minimum
Mar 2021
679.00M
Maximum
Mar 2024
586.05M
Average
589.50M
Median
Research and Development Expense (TTM) Benchmarks
| LeMaitre Vascular Inc | 17.18M |
| Outset Medical Inc | 56.15M |
| Abbott Laboratories | 2.771B |
| Boston Scientific Corp | 1.444B |
| Insulet Corp | 205.10M |